Generative AI is revolutionizing healthcare by accelerating drug discovery and combating antimicrobial resistance, with Asia’s policy-driven initiatives and North America’s…
Zoliflodacin Phase 3 trial reveals 96.4% cure rate for uncomplicated urogenital gonorrhea
A study in The Lancet shows zoliflodacin, a single-dose oral antibiotic, achieves 96.4% microbiological cure rates, matching standard care. With…
AI Surveillance Systems Cut Hospital Infections by 35% at Major US Medical Centers
Cedars-Sinai Medical Center reports 35% reduction in ICU-acquired infections through AI-powered sensor networks as WHO pushes global adoption. BioAIDiagnostics secures…